Non-vitamin K Antagonist Oral Anticoagulants in Patients With Atrial High Rate Episodes
A phase 3 trial registered on ClinicalTrials.gov. The registry status is terminated. It enrolled 2608 participants.
Also called NCT02618577
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; double masking; primary purpose prevention
- Phase
- Phase 3
- Enrolled
- 2,608 participants
- Sponsor
- Registry
-
NCT02618577 -
2015-003997-33
-
- Other papers using this trial's data
- Anticoagulation with Edoxaban in Patients with Atrial High-Rate Episodes
- Started
- (actual)
- Primary completion
- (actual)
- Completion
- (actual)
- Results first posted
- Countries
- Austria, Belgium, Bulgaria, Czechia, Denmark, France, Germany, Greece, Hungary, Italy, Netherlands, Poland, Portugal, Romania, Spain, Sweden, Ukraine, United Kingdom
- Registry status
- Terminated
Technical summary
Registry record NCT02618577. Randomized; double masking; primary purpose prevention. Start 2016-02 (actual); primary completion 2022-12-31 (actual). Results posted on 2025-02-06.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- Non-vitamin K Antagonist Oral Anticoagulants in Patients With Atrial High Rate Episodes
- Acronym
- NOAH
- Condition
- Atrial High Rate Episodes
- Intervention (Drug)
- Edoxaban
- Intervention (Drug)
- ASA
- Lead sponsor
- Atrial Fibrillation Network
- Collaborator
- Daiichi Sankyo Europe, GmbH, a Daiichi Sankyo Company
- Collaborator
- Deutsches Zentrum für Herz-Kreislauf-Forschung (DZHK)
Record details
- Record id
cardio:ct-nct02618577- Content hash
33469252e9b1150d54fe0b16bbecda7d627ab11c9cba9fabf7638655f1a33bb5